Recombinant Mouse Olfactory receptor 183 (Olfr183)

What is Mouse Olfactory Receptor 183 (Olfr183) and where is it typically expressed?

Olfr183 belongs to the largest gene family in the mouse genome, comprising nearly 1,000 genes. While traditionally associated with the olfactory epithelium, olfactory receptors like Olfr183 may also be expressed in non-olfactory tissues. To determine the expression profile of Olfr183, researchers typically use RT-PCR screening across multiple tissues including kidney, heart, skeletal muscle, lung, liver, stomach, and reproductive organs . This approach allows for characterization of tissue-specific expression patterns and potential physiological roles beyond olfaction.

How do researchers produce recombinant Olfr183 for in vitro studies?

Recombinant expression of olfactory receptors including Olfr183 is typically achieved through heterologous expression systems. A common approach involves:

• Cloning the Olfr183 gene into expression vectors

• Co-expression with G proteins (particularly Gαolf) to enable signal transduction

• Addition of trafficking enhancers to improve surface expression

For functional studies, the Xenopus oocyte expression system has proven effective, requiring co-injection of cRNAs encoding the receptor, Gαolf, and a reporter such as CFTR (Cystic Fibrosis Transmembrane Regulator) . Alternatively, mammalian cell lines (HEK293, HeLa) can be used with appropriate modifications to enhance surface trafficking.

What are the main challenges in working with recombinant olfactory receptors like Olfr183?

Working with recombinant olfactory receptors presents several methodological challenges:

• Poor surface trafficking in heterologous systems

• Protein misfolding in non-native environments

• Ligand identification complexity (most ORs remain "orphan" receptors)

• Functional validation requirements

Surface expression can be monitored through fusion with fluorescent tags (GFP, RFP) and quantified using flow cytometry or microscopy. Trafficking enhancement strategies include the use of accessory proteins or creating chimeric receptors with better-expressed GPCRs .

What computational approaches can predict potential ligands for Olfr183?

In silico approaches for ligand prediction employ homology modeling and virtual ligand screening (VLS):

• Create a homology model of Olfr183 based on available GPCR structures

• Generate a grid map of the receptor binding pocket

• Dock diverse odorant libraries against the model

• Evaluate interactions using scoring functions that account for:

  • Hydrophobicity

  • Solvation electrostatics

  • Hydrogen bonding

  • Ligand deformation energy

  • Van der Waals interactions

The most promising candidates (those with more negative scores) can then be validated experimentally. This approach has successfully identified novel ligands for other olfactory receptors like MOR42-3 .

How can knockout (KO) models be utilized to study Olfr183 function in vivo?

Knockout models provide valuable insights into receptor function through loss-of-function analysis:

• Generate Olfr183-KO mice using CRISPR/Cas9 or traditional gene targeting

• Assess phenotypic changes in:

  • Olfactory function using behavioral tests

  • Tissue-specific effects if Olfr183 is expressed outside the olfactory epithelium

  • Molecular compensation by other olfactory receptors

Analysis should account for the burden effect observed with OR-KO genes, where the cumulative impact of multiple OR knockouts correlates with worsening odor discrimination capabilities .

Table 1: Relationship between age, OR-KO gene burden, and olfactory function based on patterns observed in human studies .

What are the current methods for deorphanizing Olfr183?

Deorphanization (identifying activating ligands) requires systematic screening approaches:

• Heterologous Expression Functional Assays:

  • Luciferase reporter assays measuring cAMP elevation

  • Calcium imaging to detect receptor activation

  • Electrophysiological recordings in Xenopus oocytes

• High-throughput Screening Strategies:

  • Screening diverse odorant libraries (~100-500 compounds)

  • Testing compounds at multiple concentrations (typically 500 μM for initial screens)

  • Categorizing potential ligands based on:
    a) Known agonists of related receptors
    b) Compounds found in biofluids
    c) Microbial metabolites
    d) Common odorants

• Validation of Hit Compounds:

  • Dose-response relationships

  • Structure-activity analysis

  • Antagonist screening

What is the optimal protocol for expressing Olfr183 in Xenopus oocytes?

For functional expression in Xenopus oocytes:

• Materials Preparation:

  • Generate expression constructs for Olfr183, Gαolf, and CFTR

  • Transcribe capped cRNAs using commercial kits (e.g., mMESSAGE MACHINE)

  • Prepare Barth's saline solution (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 0.3 mM CaNO3, 0.41 mM CaCl2, 0.82 mM MgSO4, 15 mM HEPES, pH 7.6 with tetracycline)

• Oocyte Injection:

  • Select stage V oocytes

  • Inject with cRNA mixture containing approximately 40 ng Olfr183, 10 ng Gαolf, and 1.5 ng CFTR cRNA

  • Incubate at 18°C for 2-5 days in Barth's solution

• Functional Testing:

  • Prepare odorant solutions in appropriate vehicles (DMSO, ethanol, or directly in buffer)

  • Use electrophysiological recordings to measure CFTR-mediated currents in response to receptor activation

  • Include appropriate positive and negative controls

How should researchers design ligand screening experiments for Olfr183?

A comprehensive ligand screening approach includes:

• Compound Library Design:

  • Include structurally diverse odorants

  • Incorporate ligands that activate phylogenetically related ORs

  • Include compounds present in biofluids (blood, urine)

  • Test microbial metabolites and environmental compounds

• Screening Protocol:

  • Test compounds at 500 μM or highest tolerated concentration

  • Prepare stock solutions in DMSO (or appropriate vehicle)

  • Limit final DMSO concentration to 0.1% for agonist assays

  • Include positive controls (if available) and vehicle controls

  • Screen for both agonist and antagonist activity

• Data Analysis:

  • Calculate signal-to-background ratios

  • Determine Z-factor to assess assay quality

  • Implement statistical thresholds for hit identification

  • Validate hits with dose-response curves

How should researchers interpret contradictory functional data for Olfr183?

When facing contradictory results in functional studies:

• Methodological Comparison:

  • Examine differences in expression systems (mammalian cells vs. Xenopus oocytes)

  • Compare signaling readouts (calcium, cAMP, electrophysiology)

  • Assess receptor expression levels and trafficking efficiency

• Experimental Conditions Analysis:

  • Evaluate buffer compositions and pH differences

  • Compare ligand preparation methods and storage conditions

  • Assess compound purity and potential degradation

• Statistical Revaluation:

  • Determine appropriate statistical tests based on data distribution

  • Consider multiple testing corrections

  • Evaluate effect sizes rather than just p-values

Contradictions often arise from subtle methodological differences, particularly with olfactory receptors that may have multiple activation mechanisms or complex ligand interactions.

What bioinformatic approaches are useful for analyzing Olfr183 expression across tissues?

Comprehensive expression analysis involves:

• RNA-Seq Analysis:

  • Process raw sequencing data using standard pipelines

  • Normalize expression values (FPKM, TPM)

  • Compare expression across tissues and conditions

  • Identify co-expressed genes for network analysis

• Single-Cell Transcriptomics:

  • Characterize cell-type specific expression

  • Identify rare cell populations expressing Olfr183

  • Analyze developmental expression patterns

• Comparative Analysis:

  • Cross-reference expression with other olfactory receptors

  • Evaluate conservation across species

  • Identify potential tissue-specific functions based on co-expression networks

For kidney-expressed ORs, systematic RT-PCR across multiple tissues has revealed unique expression profiles, suggesting distinct physiological roles beyond olfaction .

How might Olfr183 function outside the olfactory epithelium?

Olfactory receptors expressed in non-olfactory tissues may serve diverse physiological functions:

• Potential Roles:

  • Chemical sensing of endogenous metabolites

  • Detecting microbial metabolites (e.g., short-chain fatty acids)

  • Regulating tissue-specific functions

  • Responding to environmental chemicals

• Investigation Approaches:

  • Tissue-specific knockout studies

  • Transcriptomic analysis following receptor activation

  • Metabolomic screening for endogenous ligands

  • Physiological assays relevant to the specific tissue

The discovery that olfactory receptors like Olfr78 respond to microbial metabolites suggests potential roles in host-microbiome interactions . Similar functions might be explored for Olfr183 if expressed in tissues interfacing with the microbiome.

What is the impact of Olfr183 genetic variants on olfactory function?

Analysis of genetic variants requires:

• Variant Identification:

  • Sequence Olfr183 in diverse populations

  • Identify Loss of Function (LoF) variants

  • Characterize missense variants affecting functional domains

• Functional Assessment:

  • Test variant receptors in heterologous systems

  • Evaluate trafficking and ligand responses

  • Correlate genotypes with olfactory phenotypes

• Population Analysis:

  • Calculate allele frequencies across populations

  • Assess evolutionary conservation

  • Evaluate potential selective pressures

Carriers of LoF variants in multiple olfactory receptor genes show impaired odor discrimination, with the effect more pronounced with increasing age and OR-KO burden .